ArticleMicrobiology spectrum2021
Proteolytic Processing, Maturation, and Unique Synteny of the
Yoko Fujita-Yamaguchi, Hideyuki Muramatsu, Alonso Tapia, Karine Bagramyan, Moksha Desai, Yasuhiro Takehana, Masayuki Igarashi, Yoshiki Yamaguchi, Markus Kalkum
Open access · goldAbstract read
In one paragraphArticle in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 3 institutions in 2 countries.
Yoko Fujita-YamaguchiDepartment of Diabetes Complications and Metabolism, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California, USA.
Hideyuki MuramatsuLaboratory of Microbiology, Institute of Microbial Chemistry, Tokyo, Japan.
Alonso TapiaDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California, USA.
Karine BagramyanDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California, USA.
Moksha DesaiDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California, USA.
Yasuhiro TakehanaLaboratory of Microbiology, Institute of Microbial Chemistry, Tokyo, Japan.
Masayuki IgarashiLaboratory of Microbiology, Institute of Microbial Chemistry, Tokyo, Japan.
Yoshiki YamaguchiBiomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science, Saitama, Japan.
Markus KalkumDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, California, USA.ORCID 0000-0002-9506-671X City Of Hope National Medical Center · USMicrobial Chemistry Research Foundation · JPRIKEN Center for Sustainable Resource Science · JP
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
SHA is an l-rhamnose- and d-galactose-binding lectin that agglutinates human group B erythrocytes and was first purified almost 50 years ago. Although the original SHA-producing
Indexed as
SyntenyBinding SitesChromatography, LiquidHemagglutininsHumansLectinsPolysaccharidesReceptors, Cell SurfaceRhamnoseRNA, Ribosomal, 16SStreptomycesTandem Mass SpectrometryHemagglutininsLectinsPolysaccharidesReceptors, Cell SurfaceRhamnoseRNA, Ribosomal, 16Ssaccharide-binding proteinsblood type B-specific hemagglutinationlectin syntenymicrobial lectinStreptomyces
Identifiers
PMID34468183
PMCPMC8557816
OpenAlexW3198492323
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390